REduCing Immunogenicity to PegloticasE (RECIPE) Study
Clinical trial NCT03303989 · COMPLETED
Trial details
- NCT number
- NCT03303989
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2020-04-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.